Petrovic brings significant leadership in the global medical technology sector

Imperative Care, Inc. a medical technology company developing connected innovations to elevate care for people affected by stroke and other ischemic diseases, today announced the appointment of Shacey Petrovic to the company's Board of Directors, effective immediately.

"We have been intentional in assembling the right balance of investors, executives, and industry experiences, on our board, each with their own unique and complimentary expertise and passion in elevating patient care," said Fred Khosravi, Chairman and CEO of Imperative Care. "Shacey has dedicated her career to improving care for patients while bringing tremendous value to the clinical community. It is a real privilege to have Shacey serve on our board as we benefit from her vast executive experience. We look forward to her meaningful contributions in delivering on our mission to bring more care to more patients."

Petrovic currently serves on the Board of Insulet Corporation (NASDAQ:PODD), a medical device company in the diabetes space that developed a wearable, automated product that has transformed how insulin is delivered. Previously, Petrovic was CEO of Insulet from 2019 to 2022, after serving in several other executive roles at the company. Under her leadership, the company grew from $2 billion in market cap to over $20 billion.

"I am honored to join the Imperative Care board at this exciting time in the company's history," said Petrovic. "While many companies claim to put the patient first, Imperative Care has truly built its business around the specific needs of patients affected by stroke and vascular diseases. The company's commitment to patients is palpable in its leadership and people, and evident in its impact-focused innovations that expand and connect care for patients."

Petrovic also served as President and Chief Executive Officer of Clinical Innovations, LLC, a developer and manufacturer of medical devices and diagnostics for women's health. From 2000 to 2013, she served in a number of key roles at Hologic, Inc. and Cytyc Corporation, which merged with Hologic in October 2007, including Vice President and General Manager of Hologic's GYN Surgical Products division, as well as various sales and marketing leadership roles in the U.S. and Europe.

Petrovic earned her Bachelor of Science in Biology from the University of Wisconsin. She also currently serves on the Board of Directors for Exact Sciences and Ambu A/S.

"We are thrilled to have Shacey join our board," said John Hamre, Ph.D., Chairman of Imperative Care's Nominating and Governance Committee. "She brings a wealth of insight that will further strengthen Imperative Care's work to elevate patient care and make our innovations available more broadly."

About Imperative Care, Inc.

Imperative Care is a commercial-stage medical technology company researching and developing connected innovations to elevate care for people affected by devastating vascular diseases such as stroke and pulmonary embolism. The company has four businesses focused on addressing specific gaps in treatment and care to make an impact across the entire patient journey. Imperative Care is based in Campbell, Calif. https://imperativecare.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230606005341/en/